The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

About Us

Targeted Healthcare Communications leverages the growing interest in cancer products in precision medicine and is the first publisher with a peer-reviewed journal focusing on these new products. Through our digital and print media platforms, we offer a dedicated website, two journals, and a number of multichannel programs focused on precision medicine in oncology.

Targeted Therapies in Oncology™ is dedicated to providing oncology healthcare professionals with leading-edge research, data, and treatment strategies surrounding molecular and immune system targets that may significantly improve outcomes for patients with cancer. The publication translates the latest news and advances in diagnostic testing, biomarkers, pathways, immunotherapy, and targeted therapeutics for better application into clinical practice.

The Journal of Targeted Therapies in Cancer™ aims to improve cancer patient care by providing peer-reviewed clinical articles that analyze advances in cancer targets and targeted therapies, and their application in clinical practice. The journal strives to expand oncologists' knowledge of biomarkers, pathways, diagnostics, immunotherapy, targeted therapeutics, and strategies for individualizing treatment and improving outcomes for patients with cancer.™ has a unique focus on molecular biology with expert opinions on research, management, and treatment. This oncology-focused website provides content focused on precision medicine in oncology. As cancer research continues to trend toward systems biology and molecular aberrations, the challenge facing many oncologists is staying current and up-to-date with the future of cancer therapeutics.
Related Sites
MJH Associates
Cure Today
OTC Guide
Specialty Pharmacy Times
Targeted Oncology
Rare Disease Report
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.